VICKI LARY: Open Payments
NPI 1083788665 · ITTA BENA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$680 in 32 payments from 8 companies in 2025. Trend: 2023 $478 · 2024 $782 · 2025 $680
Food & beverage: $680
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $429 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| Novo Nordisk Inc | 3 | $54 |
| Abbott Laboratories | 2 | $46 |
| Lilly USA, LLC | 2 | $45 |
| Dexcom, Inc. | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: AIRSUPRA, FARXIGA, TRELEGY ELLIPTA, Rybelsus, FREESTYLE LIBRE 3, MOUNJARO, BREZTRI, Dexcom G6 Transmitter.
Industry payments across MS — which companies pay providers there.
